VSee Health Shares Soar 190% on FedRAMP Approval and New Telehealth Contracts

Introduction

VSee Health Inc (NASDAQ: VSEE), known in Korean as 브이시 헬스, offers a customizable telehealth platform that incorporates no-code and low-code tools alongside clinician services. Its digital health stack supports the rapid deployment of white-label solutions, integrating features such as patient monitoring, e-signatures, billing, scheduling, and EHR connectivity. Founded in 2008 and headquartered in San Jose, California, VSee serves healthcare systems, government agencies, and enterprises globally.

Corporate Structure

VSee Health is a privately held company employing between 51 and 200 staff members. The leadership team comprises individuals with backgrounds in academia and industry, possessing expertise in computer science, user interface design, and healthcare innovation. Its core competencies include video telemedicine, device integration, artificial intelligence diagnostics, and remote patient monitoring. The company operates from its main office in Silicon Valley and supports a distributed engineering workforce.

Telehealth by National Cancer Institute

Recent Developments and News

• On October 15, 2025, VSee Health filed its Q3 2025 Form 10-Q, which provides financial results and operational updates for the period ending June 30, 2025.
• On October 20 and October 22, 2025, the company filed reports on Form 8-K (Acc-no: 0001185185-25-001496 and 0001185185-25-001518), detailing material corporate events and governance updates.
• In 2025, VSee Health secured a contract valued at $444,000 with a major U.S. county to develop a telehealth and data analytics platform for mental and behavioral health services.
• The company entered a partnership with a Florida health system to launch a telehealth platform for home care and community health services, and collaborated with AbundaBox on AbundaLife, a secure medical records management solution.
• VSee Health continues to participate in Project VITAL with Health Tech Without Borders and iDocta, which aims to expand telehealth services in conflict-affected regions of Cameroon.
• The U.S. Department of Health and Human Services granted VSee Health FedRAMP High Authority to Operate earlier in 2025, enabling secure deployments for federal clients.
• VSeeCON 2025, the company’s AI & Digital Health User Conference, is scheduled for November 12–13, 2025, in Silicon Valley.

Financial and Strategic Analysis

As of October 28, 2025, VSEE shares were priced at $1.79, reflecting an increase of 189.88% with a trading volume of 30,955,609 shares on the NASDAQ. The stock’s movement corresponds with newly acquired federal authorizations, contracts in mental health and home care, and the company’s expanding partner ecosystem. Strategically, VSee Health utilizes its proprietary video engine and adaptable telehealth workflows to distinguish itself from standard conferencing solutions. Investments in AI integrations and compliance with FedRAMP standards position the company for potential growth in both the commercial and public sectors.

Market Position and Industry Context

VSee Health operates within the telehealth market, which is projected to exceed $100 billion globally by 2027. Its platform competes with other HIPAA-compliant solutions—such as Amwell, Teladoc, and Zoom for Healthcare—by focusing on customization and interoperability of medical devices. Adoption by entities such as NASA’s International Space Station, McKesson, and GE Health highlights the company’s presence in government, enterprise, and specialty care. The company’s emphasis on rural health, AI diagnostics, and modular architecture aligns with the growing demand among healthcare providers for scalable, low-code virtual care solutions.

tl;dr

On October 28, 2025, VSEE shares closed at $1.79, reflecting a 189.88% increase, with a trading volume of 30.9 million shares. In Q3 2025, the company filed its Form 10-Q and two Form 8-Ks on October 15 and 20–22, providing corporate updates. During 2025, VSee Health secured a $444,000 county contract for behavioral health services, partnered with a Florida health system for home-care telehealth, and achieved FedRAMP High ATO from HHS. VSeeCON 2025 is set for November 12–13 in Silicon Valley. Future growth factors include AI-powered clinical workflows, federal deployments, and expanded international partnerships.